Molecular Communications (MC) is a bio-inspired communication paradigm which uses molecules as information carriers, thereby requiring unconventional transmitter/receiver architectures and modulation/detection techniques. Practical MC receivers (MC-Rxs) can be implemented based on field-effect transistor biosensor (bioFET) architectures, where surface receptors reversibly react with ligands, whose concentration encodes the information. The time-varying concentration of ligand-bound receptors is then translated into electrical signals via field-effect, which is used to decode the transmitted information. However, ligand-receptor interactions do not provide an ideal molecular selectivity, as similar types of ligands, i.e., interferers, co-existing in the MC channel can interact with the same type of receptors, resulting in cross-talk. Overcoming this molecular cross-talk with time-domain samples of the Rx's electrical output is not always attainable, especially when Rx has no knowledge of the interferer statistics or it operates near saturation. In this study, we propose a frequency-domain detection (FDD) technique for bioFET-based MC-Rxs, which exploits the difference in binding reaction rates of different types of ligands, reflected to the noise spectrum of the ligand-receptor binding fluctuations. We analytically derive the bit error probability (BEP) of the FDD technique, and demonstrate its effectiveness in decoding transmitted concentration signals under stochastic molecular interference, in comparison to a widely-used time-domain detection (TDD) technique. The proposed FDD method can be applied to any biosensor-based MC-Rxs, which employ receptor molecules as the channel-Rx interface.